Complete Filing Data
Suzano S.A. reported Cash And Cash Equivalents of $15.18 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Suzano S.A. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contracts With Customers | $50.12B | $47.40B | $39.76B | $49.83B | $40.97B | $30.46B | $26.01B | $13.44B | $10.58B | $9.84B |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -$409.2M | -$13.8M | -$19.4M | $284.4M | $51.9M | $36.1M | $32.0M | $7.6M | $5.9M | -$7.1M |
| Profit Loss From Operating Activities | $10.65B | $15.69B | $12.22B | $22.22B | $18.18B | $8.44B | $2.63B | $5.01B | $3.28B | $1.27B |
| Profit Loss Before Tax | $20.41B | -$13.11B | $18.00B | $28.66B | $8.83B | -$17.64B | -$4.10B | $165.3M | $2.26B | $2.40B |
| Profit Loss | $13.44B | -$7.04B | $14.11B | $23.39B | $8.64B | -$10.71B | -$2.81B | $319.8M | $1.82B | $1.68B |
| Gross Profit | $16.23B | $20.00B | $14.68B | $25.01B | $20.35B | $11.49B | $5.27B | $6.52B | $4.08B | $3.28B |
| General And Administrative Expense | $2.79B | $2.62B | $1.92B | $1.71B | $1.58B | $1.44B | $1.17B | $825.2M | $529.0M | $427.1M |
| Cost Of Sales | $33.89B | $27.40B | $25.08B | $24.82B | $20.62B | $18.97B | $20.74B | $6.92B | $6.50B | $6.56B |
| Comprehensive Income Attributable To Owners Of Parent | $13.06B | -$7.18B | $14.00B | $23.12B | $8.75B | -$10.75B | -$2.86B | $411.5M | $1.86B | $1.60B |
| Comprehensive Income | $13.09B | -$7.15B | $14.03B | $23.13B | $8.76B | -$10.74B | -$2.86B | $411.6M | $1.86B | $1.60B |
| Profit Loss Attributable To Owners Of Parent | $13.41B | -$7.07B | $14.08B | $23.38B | $8.63B | -$10.72B | -$2.82B | $319.7M | $1.82B | |
| Profit Loss Attributable To Noncontrolling Interests | $29.5M | $29.5M | $21.5M | $13.3M | $9.1M | $9.9M | $2.8M | $121.0K | ||
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | -$214.9M | -$273.3M | -$85.7M | -$10.6M | $80.3M | -$17.9M | -$93.3M | -$45.7M | $1.82B | |
| Comprehensive Income Attributable To Noncontrolling Interests | $29.5M | $29.5M | $21.5M | $13.3M | $9.1M | $9.9M | $2.8M | $121.0K | ||
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | -$129.1M | $163.2M | $5.2M | -$251.8M | $45.2M | -$2.9M | $45.8M | $137.5M | ||
| Adjustments For Interest Expense | $5.95B | $5.41B | $4.80B | $4.01B | $3.21B | $3.29B | $3.36B | $872.2M | $852.0M | $1.00B |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Trade And Other Receivables | $119.4M | $2.6M | $35.2M | $1.7M | -$637.0K | $6.0M | -$12.3M | $6.5M | $32.4M | $17.0M |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Inventories | $141.6M | $77.4M | $31.4M | $56.1M | $73.6M | $65.7M | $107.3M | -$25.1M | $26.7M | $9.6M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | -$220.3M | -$362.8M | -$1.3M | -$3.4M | $2.0M | $6.3M | $3.6M | |||
| Income Taxes Paid Refund Classified As Operating Activities | $289.5M | $366.3M | $308.0M | $306.5M | $106.2M | $188.3M | $391.7M | $327.3M | $121.2M | |
| Income Tax Relating To Investments In Equity Instruments Of Other Comprehensive Income | -$629.0K | $1.4M | -$446.0K | -$1.2M | $687.0K | $2.1M | $1.2M | |||
| Other Comprehensive Income | -$343.9M | -$110.1M | -$80.5M | -$262.4M | $125.5M | -$20.7M | -$47.4M | |||
| Interest Expense On Lease Liabilities | $467.9M | $451.1M | $441.6M | $433.6M | $427.9M | $397.7M | $226.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $15.18B | $9.02B | $8.35B | $9.51B | $13.59B | $6.84B | $3.25B | $4.39B | $1.08B | $1.61B | $1.48B |
| Adjustments For Deferred Tax Expense | $6.46B | -$7.43B | $3.50B | $4.75B | -$94.7M | -$7.11B | -$1.53B | -$741.1M | $241.9M | $530.1M | |
| Noncurrent Biological Assets | $26.10B | $22.28B | $18.28B | $14.63B | $12.25B | $11.16B | $10.57B | $4.94B | $4.55B | $4.07B | |
| Gains Losses On Fair Value Adjustment Biological Assets | -$1.52B | -$1.43B | -$1.99B | -$1.20B | -$763.1M | $466.5M | $185.4M | -$129.2M | $192.5M | -$780.7M | |
| Rightofuse Assets | $5.33B | $5.18B | $5.20B | $5.11B | $4.79B | $4.34B | $3.85B | $0.00 | |||
| Property Plant And Equipment | $64.30B | $64.99B | $59.29B | $50.66B | $38.17B | $39.16B | $41.12B | $17.02B | $16.21B | $17.02B | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $4.58B | $9.19B | $11.67B | $9.79B | $2.15B | $1.50B | $2.00B | $1.25B | $859.9M | $886.0M | |
| Purchase Of Intangible Assets Classified As Investing Activities | $82.5M | $162.0M | $104.9M | $90.5M | $285.3M | $2.3M | $17.7M | $7.2M | $8.1M | $11.6M | |
| Purchase Of Biological Assets | $7.91B | $7.18B | $5.78B | $4.96B | $3.81B | $3.39B | $2.85B | $1.16B | $912.4M | $1.43B | |
| Cash Flows From Used In Operating Activities | $18.15B | $20.60B | $17.32B | $21.64B | $17.64B | $13.12B | $7.58B | $5.17B | $3.07B | $3.08B | |
| Cash Flows From Used In Investing Activities | -$9.83B | -$20.51B | -$26.04B | -$17.02B | -$10.36B | -$736.4M | -$11.70B | -$21.96B | -$1.01B | -$3.34B | |
| Cash Flows From Used In Financing Activities | -$1.82B | -$83.8M | $7.80B | -$8.11B | -$1.57B | -$9.79B | $3.14B | $20.04B | -$2.61B | $566.1M | |
| Adjustments For Increase Decrease In Trade Account Payable | $6.6M | $2.16B | $463.0M | $1.53B | $1.36B | $140.5M | -$1.56B | $1.5M | $63.2M | -$4.7M | |
| Adjustments For Increase Decrease In Other Operating Payables | -$218.9M | -$27.7M | -$277.5M | -$9.0M | -$192.0M | -$266.5M | -$62.3M | $225.6M | -$133.8M | $1.20B | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -$91.5M | $364.8M | $73.1M | $83.7M | $97.8M | $92.3M | -$234.9M | -$100.1M | -$135.1M | $36.9M | |
| Adjustments For Gain Loss On Disposals Property Plant And Equipment | -$475.3M | -$163.0M | -$331.3M | -$509.0K | $412.6M | $8.4M | -$77.9M | -$13.6M | -$37.7M | $9.8M | |
| Adjustments For Decrease Increase In Trade Account Receivable | $1.59B | -$808.8M | $2.16B | -$3.27B | -$3.39B | $884.5M | $991.5M | -$186.0M | -$726.8M | $212.9M | |
| Adjustments For Decrease Increase In Other Operating Receivables | $259.7M | $6.2M | $328.8M | -$95.4M | -$72.8M | $54.7M | -$26.5M | -$12.7M | $414.8M | -$483.4M | |
| Adjustments For Decrease Increase In Tax Payable | $384.2M | $296.2M | $329.6M | $422.6M | $271.7M | $47.2M | $240.9M | $432.6M | $265.7M | ||
| Cash Flows From Used In Operations | $22.88B | $23.75B | $20.51B | $25.06B | $20.84B | $16.75B | $10.57B | $6.30B | $4.20B | ||
| Adjustments For Increase Decrease In Provision Reversal For Judicial Liabilities | -$49.8M | $138.3M | $139.9M | $88.2M | $65.3M | $1.3M | $26.8M | $13.3M | $35.6M | ||
| Adjustments For Increase Decrease In Accrual Of Interest On Marketable Securities | $1.03B | $1.25B | $1.35B | $707.2M | $178.3M | $94.9M | $392.0M | $127.0M | $24.2M | ||
| Depreciation Rightofuse Assets | $384.0M | $349.1M | $321.3M | $232.0M | $203.7M | $186.8M | $154.2M | ||||
| Liabilities | $123.98B | $133.52B | $98.78B | $100.03B | $103.80B | $94.46B | $79.82B | $41.91B | $16.91B | $19.25B | |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | $22.0M | $41.3M | $48.5M | $67.0M | $51.8M | $45.9M | $294.5M | ||||
| Assets | $167.94B | $165.94B | $143.59B | $133.20B | $118.98B | $101.80B | $97.91B | $53.93B | $28.53B | $29.37B | |
| Trade And Other Current Payables To Trade Suppliers | $5.14B | $6.03B | $5.57B | $6.21B | $3.29B | $2.36B | $2.38B | $632.6M | $621.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Borrowings Classified As Financing Activities | $23.87B | $15.69B | $10.94B | $1.34B | $16.99B | $14.76B | $18.99B | $25.65B | $2.56B | $5.67B |
| Payments For Proceeds From Financial Investments | -$2.94B | -$206.0M | $5.30B | -$67.4M | $5.22B | -$3.84B | -$19.38B | $19.34B | -$687.3M | $1.05B |
| Increase Decrease In Cash And Cash Equivalents | $6.50B | $7.9M | -$921.0M | -$4.08B | $6.76B | $3.59B | -$1.14B | $3.31B | -$537.9M | $137.5M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$338.9M | $665.0M | -$239.1M | -$602.5M | $1.05B | $982.9M | -$161.6M | $67.4M | $14.7M | -$161.7M |
| Payments For Proceeds From Derivative Transactions | -$530.7M | $550.6M | -$3.56B | -$282.2M | $1.92B | $4.47B | $135.4M | $1.59B | -$39.7M | -$117.3M |
| Payments For Acquisition Of Assets Classified As Financing Activities | $20.7M | $58.5M | $116.9M | $107.9M | $153.4M | $164.2M | $479.5M | $84.1M | $117.9M | $72.4M |
| Payments Of Lease Liabilities Classified As Financing Activities | $1.45B | $1.33B | $1.22B | $1.04B | $1.01B | $824.2M | $645.1M | |||
| Proceeds From Disposals Of Property Plant And Equipment Intangible Assets Other Than Goodwill Investment Property And Other Noncurrent Assets | $122.7M | $168.0M | $183.6M | $251.2M | $1.41B | $183.5M | $198.6M | $95.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $10.82 | $-5.59 | $10.85 | $17.57 | $6.39 | $-7.95 | $-2.09 | $0.29 | $1.66 | $1.53 |
| Basic Earnings Loss Per Share | $10.84 | $-5.59 | $10.86 | $17.58 | $6.39 | $-7.95 | $-2.09 | $0.29 | $1.67 | $1.54 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling Expense | $3.31B | $2.94B | $2.60B | $2.48B | $2.29B | $2.17B | $1.91B | $598.7M | $423.3M | $416.3M |
| Other Operating Income Expense | $934.9M | $1.26B | $2.08B | $1.12B | $1.65B | $531.2M | $405.8M | -$96.9M | $140.5M | -$1.15B |
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$105.4M | $163.2M | $4.7M | -$16.0M | $46.0M | -$2.9M | $45.8M | $137.5M | $38.0M | -$45.7M |
| Finance Income | $1.77B | $1.74B | $1.83B | $967.0M | $272.6M | $327.5M | $493.2M | $459.7M | $305.8M | $2.28B |
| Finance Costs | $6.88B | $5.54B | $4.66B | $4.59B | $4.22B | $4.46B | $4.18B | $1.50B | $1.22B | $1.16B |
| Current Tax Expense Income And Current Social Contribution Tax Expense Income | $518.4M | $1.37B | $395.4M | $510.9M | $292.1M | $181.9M | $246.1M | $586.6M | $202.2M | $188.8M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $7.55B | -$15.88B | $3.09B | $3.29B | -$3.80B | -$12.53B | -$1.96B | -$1.07B | -$179.4M | |
| Gains Losses On Change In Fair Value Of Derivatives | $7.33B | -$9.11B | $5.53B | $6.76B | -$1.60B | -$9.42B | -$1.08B | -$2.74B | ||
| Treasury Shares | 1.51B | 1.34B | 1.48B | 2.12B | 218.3M | 218.3M | 218.3M | 218.3M | 241.1M | 273.7M |
| Repayments Of Borrowings Principal | $22.35B | $9.41B | $4.30B | $2.52B | $15.47B | $19.09B | $13.99B | $3.74B | $4.53B | $4.85B |
| Interest Paid Classified As Operating Activities | $5.82B | $5.24B | $4.73B | $4.02B | $2.95B | $3.24B | $2.98B | $806.8M | $1.01B | $1.10B |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$7.55B | $15.88B | -$3.09B | -$3.29B | $3.80B | $12.53B | $1.96B | $1.45B | $2.3M | -$1.44B |
| Adjustments For Depreciation And Amortisation Expense | $10.91B | $8.87B | $7.00B | $7.21B | $6.88B | $6.57B | $7.90B | $1.56B | $1.40B | $1.40B |
| Adjustments For Decrease Increase In Recoverable Taxes | -$413.4M | -$95.4M | -$666.7M | -$381.4M | $186.0M | $659.9M | $241.9M | $51.0M | $8.7M | -$39.7M |
| Adjustments For Decrease Increase In Inventories | -$216.4M | -$863.6M | -$48.7M | -$968.0M | -$654.8M | $651.2M | $873.4M | -$622.2M | $115.5M | -$47.8M |
| Increase Decrease Through Sharebased Payment Transactions | $45.6M | $81.3M | $8.3M | $5.3M | $4.8M | $4.6M | $879.0K | $5.2M | $1.5M | $3.3M |
| Amortization Of Fundraising Costs | $101.9M | $80.1M | $67.4M | $69.9M | $107.2M | $101.7M | $185.8M | $44.5M | $49.5M | |
| Adjustments For Interest On Employee Benefits | $79.3M | $75.9M | $69.2M | $59.3M | $55.8M | $53.1M | $44.5M | $35.9M | $38.0M | |
| Interest Received Classified As Operating Activities | $1.21B | $1.50B | $681.3M | $544.8M | $98.1M | $186.9M | $377.8M |
Most recent annual filing with the SEC: March 24, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.